Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sertraline - Pfizer

Next Previous
X
Search
Drug Profile

Sertraline - Pfizer

Alternative Names: Aremis; Besitran; CP 51974; CP 51974 01; Gladem; J Zoloft; Lustral; Serad; Serlain; Tatig; Zoloft

Latest Information Update: 05 Nov 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Amines; Antidepressants; Anxiolytics; Naphthalenes; Small molecules
  • Mechanism of Action Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Major depressive disorder; Obsessive-compulsive disorders; Panic disorder; Post-traumatic stress disorders; Premenstrual dysphoric disorder; Social phobia
  • No development reported Generalised anxiety disorder
  • Discontinued Night eating syndrome; Premature ejaculation

Most Recent Events

  • 15 Aug 2023 Otsuka Pharmaceutical completed a phase III trial for Post-traumatic stress disorder (Combination therapy) in USA (PO) (NCT04174170)
  • 30 Oct 2019 Otsuka Pharmaceutical initiates enrolment in a phase III trial for Post-traumatic stress disorder (Combination therapy) in USA (PO) (NCT04174170)
  • 01 Sep 2016 Pfizer completes a phase I trial in Healthy volunteers in Belgium (NCT02651623)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top